Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Calmark Sweden AB: Calmark receives order from India

Download the release

Calmark Sweden AB (publ) announces today that an order for 50 instruments and 2,000 test cassettes relating to the Calmark Neo-Bilirubin product has been received from the Company's distributor in India, r2 Diagnostics. The registration process in India for the products is ongoing and is anticipated to be completed shortly.

Today's order comprises 50 instruments with associated test cassettes to be dispatched to end customers in selected children's hospitals in India according to a release plan. The order will be delivered as soon as the registration process is completed. 

"I am very pleased that things are under way in the vast and important market of India. The fact that this order arrives before the registration process is fully completed shows that the distributor is committed and really eager to shorten the time-to-delivery for customers," says Magdalena Tharaldsen, Calmark's Director International Business Development. "Approximately 25 million children are born every year in India, and the market for bilirubin blood tests exceeds 7.5 million tests."

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
 

This disclosure contains information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 19-08-2022 08:39 CET.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.